Skip to main content
Total Market Cap: $43,730,586,646 Volume (24h): $739,348,100

CV Sciences Inc.

CV Sciences Inc. (CVSI) logo
Rank 53
About

The American-based operation at CV Sciences is split across two fronts. The first, consumer products, supplies hemp-derived CBD oils through a subsidiary branded “PlusCBD Oil”. The second focus for the company is the pursuit of pharmaceutical-grade drugs with cannabidiol as the active ingredient. With the support of preclinical results, they are actively pursuing FDA approval for medication aimed at a range of health conditions. 

Website
$0.5700
USD
5.45%
Market cap
$57,236,865
Total volume
$197,789
Shares outstanding
100,415,553
Reserved shares
89,584,447
Rank 53
Website
About

The American-based operation at CV Sciences is split across two fronts. The first, consumer products, supplies hemp-derived CBD oils through a subsidiary branded “PlusCBD Oil”. The second focus for the company is the pursuit of pharmaceutical-grade drugs with cannabidiol as the active ingredient. With the support of preclinical results, they are actively pursuing FDA approval for medication aimed at a range of health conditions. 

Markets
Exchange Symbol Volume (24h) Volume (%) Price
OTC
CVSI
$197,789
100%
$0.5700
Chart
Social media
Tweets by @CV_Sciences
CV Sciences Inc.

Share widget

Copy widget code
Subscribe to our newsletter